Obama
The year in review 2013
December 13, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2014, NHS, Obama, adams, review of the year
The year 2013 brought a new series of challenges for pharma. As the dust settled following the bulk of major …
UK government doubles dementia funding
December 11, 2013Research and Development, Sales and Marketing Alzheimer's, Cameron, Merck, Obama, dementia
UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …
Obamacare: health reform’s tough start
November 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Obamacare, US, affordable care act
On Tuesday 1 October, three years after it was passed, the Patient Protection and Affordable Care Act came into force …
US shutdown affecting medical science
October 11, 2013Research and Development, Sales and Marketing FDA, Obama, Obamacare, us shutdown
American scientists and the latest Nobel Prize winners have condemned the US shutdown this week saying it is putting scientific …
US shutdown starts to bite – UPDATED
October 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, FDA, Medicare, Obama, Obamacare
Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …
The fight over ‘Obamacare’ goes on
July 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Medicaid, Obama, Obamacare, Romney, US, healthcare
The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …
Lechleiter wants policy that spurs innovation
June 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Lechleiter, Obama, PhRMA, US, heathcare, lilly
Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …
Pharma critical of Obama budget
February 15, 2012Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform
President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Obama takes action to curb medicine shortages
November 1, 2011Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs
US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …
Obama proposes seven year rule for biologics
September 21, 2011Research and Development, Sales and Marketing Obama, biologics
President Obama has returned to the issue of market exclusivity for biologic drugs as a way of cutting healthcare costs. …
US debt deal could hit pharma
August 2, 2011Sales and Marketing Obama, PhRMA, US, healthcare reform
The deal to raise America’s debt ceiling could have long-term consequences for the US pharma industry. The tense stand-off between …
Obama’s generics plan criticised
February 15, 2011Sales and Marketing FDA, Obama, PhRMA, generics, reform
US pharma says new plans to end ‘pay-for-delay’ generics deals and shave five years from biologics exclusivity will threaten innovation …
2010: Pharma’s year in review
December 23, 2010Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review
2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
